The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
The freshly infused capital will primarily be deployed towards expansion and research & development
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Announces Rs. 317 crore investment in new recycling plant
Subscribe To Our Newsletter & Stay Updated
